LoginSignup
Roche Holdings logo

Roche Holdings Stock

StockStock
ISIN: CH0012032048
Ticker: ROG
CH0012032048
ROG

Price

Historical dividends and forecast

All dividend data

Roche Holdings has so far distributed $10.82 in 2024. The next dividend will be paid on 18.03.2025

$4.507

CHART BY

Frequently asked questions

What is Roche Holdings's market capitalization?

The market capitalization of Roche Holdings is $252.84B. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.

What is Roche Holdings's Price-to-Earnings (P/E) ratio?

The Price-to-Earnings (P/E) ratio (TTM) for Roche Holdings is 20.25. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.

What is the Earnings Per Share (EPS) for Roche Holdings?

Roche Holdings's Earnings Per Share (EPS) over the trailing twelve months (TTM) is $15.24. EPS indicates the company's profitability on a per-share basis.

What are the analyst ratings and target price for Roche Holdings's stock?

Currently, 23 analysts cover Roche Holdings's stock, with a consensus target price of $313.25. Analyst ratings provide insights into the stock's expected performance.

What is Roche Holdings's revenue over the trailing twelve months?

Over the trailing twelve months, Roche Holdings reported a revenue of $67.71B.

What is the EBITDA for Roche Holdings?

Roche Holdings's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $25.76B. EBITDA measures the company's overall financial performance.

What is the free cash flow of Roche Holdings?

Roche Holdings has a free cash flow of $3.82B. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.

What is the 5-year beta of Roche Holdings's stock?

The 5-year beta for Roche Holdings is 0.73. A beta value indicates the stock's volatility relative to the market; a beta greater than 1 means higher volatility.

How many employees does Roche Holdings have, and what sector and industry does it belong to?

Roche Holdings employs approximately 103,605 people. It operates in the Health Care sector, specifically within the Biotechnology & Drugs industry.

What is the free float of Roche Holdings's shares?

The free float of Roche Holdings is 719.12M. Free float refers to the number of shares available for public trading, excluding restricted shares.

Financials

Market Cap

 $252.84B

5Y beta

 0.73

EPS (TTM)

 $15.24

Free Float

 719.12M

P/E ratio (TTM)

 20.25

Revenue (TTM)

 $67.71B

EBITDA (TTM)

 $25.76B

Free Cashflow (TTM)

 $3.82B

Pricing

1D span
$309.58$312.03
52W span
$233.19$333.97

Analyst Ratings

The price target is $313.25 and the stock is covered by 23 analysts.

Buy

9

Hold

9

Sell

5

Information

Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The Company offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.

103,605

Biotechnology & Drugs

Health Care

Identifier

ISIN

CH0012032048

Primary Ticker

ROG

Knockouts

Join the conversation
Sign upLogin